外泌體分子生物標誌

• l安吉譜技術平台(AngelZip)：以外泌體關聯之分子標誌為標的，應用於檢測極早期之疾病或老化進程，供醫師診斷參考。

真菌蕈菇外泌體醱酵生產專業技術

• 真菌外泌體生產技術平台(MycoGen)：以固態或液態醱酵技術，生產真菌蕈菇外泌體。

團隊

• 專職人員：生技產業年資合計超過40年，經驗含括新藥開發、有機化學合成、免疫與過敏、分子標誌檢測、動物試驗、分子生物技術、微生物醱酵、生理活性物質生合成途徑等等。
• 顧問群：生技智財權、腫瘤細胞生物學、外泌體、臨床醫學、真菌多樣性、天然物分析、食品加工、農業生技、腸道菌、蛋白質體學等等學研專家。

願景

• 如同《黃帝內經》「上醫醫未病，中醫醫欲病，下醫醫已病」所述，身體機能的保養照護為基要，搭配疾病早期診斷，乃是最佳的健康對策。紅隼兆生醫成立之宗旨欲以「安吉譜(AngelZip)」高靈敏度的技術平台，早期發現潛在病變 (例如癌腫瘤及老化等)，在常規的醫療措施實施之前或同時，施以蕈菇真菌所分泌之外泌體食品，以促進健康或預防疾病的進程，提升生活品質。

Company

• Accurome was founded by a team with extensive experience in precision medicine and molecular biotechnology, focusing on human exosome biomarkers for disease detection technology and fungal exosomes for health promotion.

Science and Technology

• Utilizing AngelZip®, a state-of-the-art technology platform, Accurome identified multiple molecular markers (microRNA and proteins) in exosomes, which are expected to be useful in detecting colorectal and breast cancer at different stages of progression with high sensitivity and high specificity. Molecular markers for other cancers, such as lung and pancreatic cancer, are also being explored and developed.
• In addition, Accurome has also established a fungal exosome production technology platform (MycoGen): using solid or liquid fermentation technology to produce functional fungal exosomes for health promotion.